Contrast enhanced ultrasound in liver imaging.

[1]  S. Taylor-Robinson,et al.  Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. , 1998, Radiology.

[2]  Tetsuya Kaneko,et al.  Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. , 2002, Journal of hepatology.

[3]  Thomas Albrecht,et al.  Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent , 1999, The Lancet.

[4]  D O Cosgrove,et al.  Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. , 1999, Radiology.

[5]  B. Skjoldbye,et al.  Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusion. , 2002, Ultrasound in medicine & biology.

[6]  S. Goldberg,et al.  Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. , 2001, AJR. American journal of roentgenology.

[7]  S. M. Ellis,et al.  Hepatic artery stenosis following liver transplantation: significance of the tardus parvus waveform and the role of microbubble contrast media in the detection of a focal stenosis. , 2002, Clinical radiology.

[8]  J. Bruix,et al.  Contrast‐enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation , 2003, Journal of clinical ultrasound : JCU.

[9]  Thomas Albrecht,et al.  Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. , 2003, Radiology.

[10]  J. Esteban,et al.  Improved detection of liver metastases with contrast-enhanced wideband harmonic imaging: comparison with CT findings. , 2002, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[11]  L Solbiati,et al.  Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience. , 1999, Radiology.

[12]  J. Hohmann,et al.  Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. , 2003, European journal of radiology.

[13]  D. Häussinger,et al.  Pulse Inversion Sonography in the Early Phase of the Sonographic Contrast Agent Levovist , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[14]  Jae Young Lee,et al.  Improved sonographic imaging of hepatic hemangioma with contrast-enhanced coded harmonic angiography: comparison with MR imaging. , 2002, Ultrasound in medicine & biology.

[15]  O. Catalano,et al.  Splenic Trauma: Evaluation With Contrast‐Specific Sonography and a Second‐Generation Contrast Medium , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[16]  W. Kaiser,et al.  Radio-frequency ablation of VX2 rabbit tumors: assessment of completeness of treatment by using contrast-enhanced harmonic power Doppler US. , 2002, Radiology.

[17]  D. Häussinger,et al.  Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. , 2002, AJR. American journal of roentgenology.

[18]  P A Osterhammel,et al.  Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. , 2001, The British journal of radiology.

[19]  N Weissman,et al.  Ultrasound imaging with SonoVue: low mechanical index real-time imaging. , 2002, Academic radiology.

[20]  Flemming Forsberg,et al.  Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. , 2002, Radiology.

[21]  M. Kudo,et al.  Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. , 2001, Radiology.

[22]  K. Shirato,et al.  Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. , 2003, AJR. American journal of roentgenology.

[23]  G. Schmid-Schönbein,et al.  Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats. , 2002, Radiology.

[24]  Sachiko Tanaka,et al.  Dynamic sonography of hepatic tumors. , 2001, AJR. American journal of roentgenology.

[25]  P. Sidhu,et al.  Assessment of portal venous system patency in the liver transplant candidate: a prospective study comparing ultrasound, microbubble-enhanced colour Doppler ultrasound, with arteriography and surgery. , 2002, Clinical radiology.

[26]  C. McArdle,et al.  Contrast‐Enhanced Doppler Perfusion Index , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[27]  D. Cosgrove,et al.  Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases , 2000, The Lancet.